Given the role of PIK3CA in breast cancer pathogenesis and as a predictive biomarker as well, we performed a mutational analysis focused on the most (approximately 90%) common PIK3CA variants described in breast cancer. This evidence concerns the gene PIK3CA and breast cancer.